Eli Lilly (LLY) seeks EMA reevaluation of a recent decision in which an expert panel of the agency denied EU approval for its Alzheimer's. therapy.
https://seekingalpha.com/news/4435867-eli-lilly-seeks-review-eu-alzheimers-drug-denial
Eli Lilly (LLY) seeks EMA reevaluation of a recent decision in which an expert panel of the agency denied EU approval for its Alzheimer's. therapy.
https://seekingalpha.com/news/4435867-eli-lilly-seeks-review-eu-alzheimers-drug-denial
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.